New Zealand – Developed Methane Vaccine Attracts $9 Million In Global Funding

Portrait of Bridget Hawkins
Chair Bridgit Hawkins said the company’s focus has always been on developing a solution that fits the realities of farming.

Auckland, New Zealand. Global confidence is converging behind a New Zealand-developed methane vaccine that could provide one of the first practical emissions solutions for grazing livestock, with Lucidome Bio securing $9 million in new funding to accelerate development of its breakthrough platform.

The funding round brings together support from existing investors Bezos Earth Fund, Meat & Livestock Australia (MLA), majority shareholder AgriZeroNZ and the NZ Ag Emissions Centre, reflecting growing confidence from agricultural, climate and innovation leaders in the company’s science, global relevance and commercial potential.

The funding will accelerate development of Lucidome Bio’s methane vaccine, support continued advancement of its research and fund a series of cattle trials scheduled to commence over the next 18 months.

Visit https://www.scoop.co.nz/ to read the full story.